Medtronic plc
MDT Real Time Price USD$MDT is featured in our Dan Meuser and Shelley Moore Capito strategies.
All StrategiesRecent trades of MDT by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in MDT holdings by institutional investors
Quarterly net insider trading by MDT's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Former government officials who have lobbied for MDT
45 former government officials from 28 congressional offices at 8 lobbying firms have lobbied for MDT, most recently Apr 20, 2026.
-
Eli Kogan House New Legislative Assistant, Rep. Joseph Crowley, NY-14 -
Earl Flood House New Dep. CoS, LD (Rep. Robin Kelly); Health Pol Adv, Csl (Rep. Terri Sewell); Csl (Rep. Cedric Richmond); Pol Aide (Sen. Claire McCaskill) -
Joseph Brown Senate New Sr Prof Staff (EPW Comm Maj/Sen. Moore Capito); Prof Staff (EPW Comm Min/Ranking Mem Sen. Moore Capito); Leg Asst (Sen. Boozman); Maj Leg Asst (EPW Comm Maj/Sen. Jim Inhofe); Maj Research Asst (EPW Comm Maj/Sen. Jim Inhofe); Intern (Rep. Jim Renacci) -
Jon Adame Senate New CoS, LD, GC (Sen. Blackburn); Counsel (Rep. Blackburn); Policy Coordinator (House E&C); Intern (Sen. Domenici) -
Annie Wolf House New Dep Floor Dir (Maj Leader Scalise); CoS (Chief Dep Min Whip Ferguson); Dep Floor Dir (Min Whip Scalise); Prof Staff (House Rules/Sessions); Floor Asst (Speakers Ryan & Boehner); Staff Asst (Speaker Boehner); Intern (Rep. Sullivan)
-
Naveen Parmar Senate New Chief Counsel (Sen. Hickenlooper); General Counsel (House Comm on Sm Bus/Velazquez); Tax Counsel, (House Comm on Sm Bus/Velazquez); Economic Policy Counsel (Sen. Amy Klobuchar); Ways and Means Counsel (Rep. Lloyd Doggett) -
Henry Menn Senate Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
-
Alyene Mlinar House New Pol Adv (Maj Leader Scalise); Pol Adv (Min Whip Scalise); Pol Adv (House Oversight/Govt Reform Comm); Prof Staff Member (Ways and Means Subcom on Health/Brady), Pol Adv (Sen Rep Policy Comm/Barrasso); Leg Asst (Senator Ben Sasse)
MDT Estimated quarterly lobbying spending
MDT Revenue by Segment or Geography
New MDT patent grants
-
Patent Title: Implantable cardiac monitor Aug. 29, 2023
-
Patent Title: Implantable cardiac monitor Aug. 29, 2023
-
Patent Title: Tool handle Feb. 28, 2023
-
Patent Title: Plunger Jan. 24, 2023
-
Patent Title: Incision tool Oct. 18, 2022
-
Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Aug. 16, 2022
-
Patent Title: Implantable cardiac monitor Jul. 12, 2022
-
Patent Title: Docking station of a recharger for an internal neural stimulator Jul. 05, 2022
-
Patent Title: Tibial implantable neurostimulator with suture loop May. 24, 2022
-
Patent Title: Tibial implantable neurostimulator May. 24, 2022
-
Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Mar. 15, 2022
-
Patent Title: Implantable medical device Mar. 08, 2022
-
Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Mar. 08, 2022
-
Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Feb. 22, 2022
-
Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Feb. 22, 2022
-
Patent Title: Recharger of an internal neuralstimulator Nov. 30, 2021
-
Patent Title: Display screen or portion thereof with graphical user interface Sep. 14, 2021
-
Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Aug. 17, 2021
-
Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Jun. 15, 2021
-
Patent Title: Systems and methods for leadless cardiac resynchronization therapy Nov. 24, 2020
-
Patent Title: Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing Sep. 08, 2020
-
Patent Title: Telemetry module for a therapeutic medical device Jun. 02, 2020
-
Patent Title: Display screen with blood pump icon Mar. 31, 2020
-
Patent Title: Dialysis recharger cabinet Mar. 03, 2020
-
Patent Title: Display screen with graphical user interface for patient monitoring during a hemodialysis session Mar. 03, 2020
-
Patent Title: Display screen or portion thereof with graphical user interface Feb. 18, 2020
-
Patent Title: Shelf system Nov. 26, 2019
-
Patent Title: Top for a dialysis recharger cabinet Oct. 08, 2019
-
Patent Title: Dialysis recharger cabinet May. 22, 2018
-
Patent Title: Door for a dialysis recharger cabinet May. 08, 2018
-
Patent Title: Top for a dialysis recharger cabinet Mar. 13, 2018
-
Patent Title: Medical device programmer Mar. 13, 2018
-
Patent Title: Interventional medical systems, catheters, and subassemblies Dec. 19, 2017
-
Patent Title: Implantable medical device fixation Dec. 19, 2017
-
Patent Title: Methods for electrode assemblies including at least one insulative portion Dec. 12, 2017
-
Patent Title: Identifying lead insulation breaches and externalization of lead conductors Dec. 12, 2017
-
Patent Title: Magnetic field detectors, implantable medical devices, and related methods that utilize a suspended proof mass and magnetically sensitive material Dec. 12, 2017
-
Patent Title: Facilitating integrity of telemetry connectivity between an implantable device and a remote device Dec. 05, 2017
-
Patent Title: Implantable medical device delivery with inner and outer sheaths Dec. 05, 2017
-
Patent Title: System and method for cardiac lead Dec. 05, 2017
-
Patent Title: Embedded metallic structures in glass Nov. 28, 2017
-
Patent Title: Ph buffer measurement system for hemodialysis systems Nov. 28, 2017
-
Patent Title: Prosthetic heart valve devices and methods of valve replacement Nov. 28, 2017
-
Patent Title: Minimally invasive implantable neurostimulation system Nov. 28, 2017
-
Patent Title: Indication of coupling between medical devices Nov. 21, 2017
-
Patent Title: Cord carrier for portable dialysis cabinet Sep. 26, 2017
-
Patent Title: Means and method of replacing a heart valve in a minimally invasive manner Mar. 12, 2013
-
Patent Title: World wide patient location and data telemetry system for implantable medical devices Nov. 15, 2011
-
Patent Title: Rf coupled, implantable medical device with rechargeable back-up power source Sep. 06, 2011
-
Patent Title: Valve holder for tricuspid heart valve May. 24, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded to MDT from public contracts
Recent insights relating to MDT
Recent picks made for MDT stock on CNBC
ETFs with the largest estimated holdings in MDT
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $MDT stock a Buy, Sell, or Hold?
- What is the price target for $MDT stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $MDT stock?
- Who owns the most shares of $MDT stock?
- What funds own $MDT stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MDT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Medtronic plc (MDT) Historical Stock Prices
Daily open, high, low, close, adjusted close and volume for Medtronic plc (MDT).
Quiver Premium charts MDT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at MDT, per a recent SEC DEF 14A filing. We estimate that the median employee at Medtronic plc is paid $67,769.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|